Stockwinners Market Radar for February 21, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

MCD...

Hot Stocks

20:07 EST Fly Intel: Top five weekend stock stories - Catch up on the weekend's top five stories with this list compiled by The Fly: 1. McDonald's (MCD) board issued a statement in response to a director notification nomination from Carl Icahn, which said in part, "McDonald's can confirm that Carl Icahn has nominated Leslie Samuelrich and Maisie Ganzler to stand for election at the 2022 Annual Meeting. There is no shareholder action required at this time. The Board will evaluate the nominees as it would any other candidates proposed to it... Mr. Icahn's stated focus in making this nomination relates to a narrow issue regarding the Company's pork commitment, which The Humane Society U.S. has already introduced through a shareholder proposal. This is an issue on which McDonald's has been a leader...Mr. Icahn, who states that he holds 200 shares of McDonald's stock, is the majority owner of Viskase, a company that produces and supplies packaging for the pork and poultry industry. Mr. Icahn's ownership provides him with unique exposure to the industry-wide challenges and opportunities in migrating away from gestation crates. Thus, it's noteworthy that Mr. Icahn has not publicly called on Viskase to adopt commitments similar to those of McDonald's 2012 commitment. Despite McDonald's progress, Mr. Icahn has instead asked for new commitments, including to require all of McDonald's U.S. pork suppliers to move to 'crate free' pork, and set specific timeframes for doing so. While the Company looks forward to promoting further collaboration across the industry on this issue, the current pork supply in the U.S. would make this type of commitment impossible." 2. The boards of Clipper Logistics (CLPLF) and GXO Logistics (GXO) announce that they have reached agreement on the key terms of a possible cash and share offer for Clipper by GXO. The board of Clipper has confirmed to GXO that, should a firm offer be made on the financial terms of the possible offer, it is minded to recommend it unanimously to Clipper shareholders. The possible offer is to acquire each Clipper ordinary share for a combination of cash and new GXO shares as follows: 690 pence in cash; and such number of new GXO shares as would imply a valuation of 230 pence based on the trailing GXO 3-month volume weighted average price and a trailing 3-month average USD/GBP exchange rate in each case calculated for the period ending on the last practicable date prior to any firm offer announcement. Accordingly, on the basis of the exchange ratio, the possible offer will imply a total valuation of 920 pence per Clipper ordinary share. 3. It may be time for some changes at Berkshire Hathaway as CEO Warren Buffett starts to look ahead to his 92nd birthday later this year, Andrew Bary wrote in this week's edition of Barron's. Over 57 years, Buffett built Berkshire Hathaway (BRK.A, BRK.B) into a company with a $700 billion market value and $27 billion of annual operating earnings. Yet the author's view has been that he now needs to do more to prepare for the transition to a new generation of leadership at Berkshire. Stepping down as CEO while remaining chairman would allow his heir apparent, Greg Abel, to demonstrate that he can handle the tough job of running a giant conglomerate, Bary added. 4. Sony's (SONY) "Uncharted" won the long Presidents Day weekend with a $51M debut, including $44.2M for the three days. The movie, a video game adaptation, stars Tom Holland and Mark Wahlberg. Overseas, "Uncharted" grossed an estimated $139M through Monday. The movie will only hit cinemas in China on March 14. 5. Ethan Allen (ETD), DuPoint (DD), and Nokia (NOK) saw positive mentions in this week's edition of Barron's.
NVT

Hot Stocks

18:01 EST nVent Electric announces quarterly cash dividend - nVent Electric announced today that it will pay a regular quarterly cash dividend of US$0.175 per ordinary share on May 6, 2022, to shareholders of record at the close of business on April 22, 2022.
MTW

Hot Stocks

17:47 EST David Antoniuk to be succeeded by Brian Regan as Manitowoc CFO - The Manitowoc announced that David Antoniuk will step down as Chief Financial Officer effective May 2, 2022, and will be succeeded by Brian Regan. Antoniuk will transition into an advisory role to the CEO until January 2, 2023, at which time he will retire from the Company.
WNC

Hot Stocks

17:35 EST Wabash announces quarterly dividend of 8c per share - Wabash National Corporation announced that its board of directors declared a regular quarterly dividend of 8c per share of the company's common stock, payable on April 28, 2022, to stockholders of record on April 7, 2022.
INNV

Hot Stocks

17:35 EST InnovAge says CMS denied application to develop PACE center in Terre Haute, IN - In a regulatory filing after the close on Friday, InnovAge Holding Corp. disclosed that on February 14, the company received notice from the Centers for Medicare & Medicaid Services, or "CMS," stating that CMS denied the company's application to develop the previously announced PACE center in Terre Haute, IN, which was projected to open in fiscal year 2024. "The denial was based on deficiencies detected during CMS' 2021 audits of the company's Sacramento and Colorado PACE programs. The company continues to be committed to operating in the state of Indiana and is evaluating its options for the future. The company cannot guarantee the outcome of this process," InnovAge stated in its filing.
PNR

Hot Stocks

17:34 EST Pentair announces quarterly cash dividend of 21c per share - Pentair announced that it will pay a regular quarterly cash dividend of 21c per share on May 6, 2022 to shareholders of record at the close of business on April 22, 2022.
AAN

Hot Stocks

17:04 EST Aaron's Directors raise cash dividend 12.5% - The Aaron's announced that its Board of Directors has raised its quarterly cash dividend to $0.1125 per share and declared such dividend payable April 5, 2022, to shareholders of record as of the close of business on March 17, 2022. This is an increase of 12.5% from the previous quarterly cash dividend of $0.10 per share.
DOOR

Hot Stocks

16:38 EST Masonite announces $200M additional share repurchase program - Masonite announced that its Board of Directors has approved a new share repurchase program allowing the company to repurchase up to an additional $200 million of its outstanding common shares. The new authorization, plus approximately $156 million currently available under its existing share repurchase authorization approved in August 2021, provides the company with over $350 million available for future share repurchase activity. As part of its ongoing commitment to drive shareholder value, the company announced that its Board of Directors has authorized it to enter into an accelerated share repurchase transaction as part of the new share repurchase program. The company intends to enter into an ASR transaction during the first quarter of 2022 for the repurchase of $100 million of its outstanding common shares.
DDD

Hot Stocks

16:37 EST 3D Systems, Saremco Dental AG enter strategic partnership - 3D Systems and Saremco Dental AG announced a strategic partnership to bring together "the power of 3D Systems' industry-leading NextDent digital dentistry solution with Saremco's materials science expertise - enabling dental laboratories and clinics to address a variety of indications with unparalleled accuracy, repeatability, productivity, and lower total cost," the companies said. To facilitate these capabilities, the companies are also announcing the immediate availability of CROWNTEC material to be used with 3D Systems' award-winning NextDent 5100 dental 3D printer and industry-leading software for the production of patient-specific permanent crowns.
SLN

Hot Stocks

16:08 EST Silence Therapeutics appoints Craig Tooman President, Chief Executive Officer - Silence Therapeutics announced that Craig Tooman, previously Chief Financial Officer, has been appointed President, Chief Executive Officer and Board member of Silence, and Mark Rothera has stepped down as President, CEO and Board member, effective immediately. Rhonda Hellums, previously Vice President, Finance, has been appointed CFO.
MRO

Hot Stocks

15:41 EST Marathon Oil promotes Rob White to VP, Controller, Chief Accounting Officer - Marathon Oil announced that Rob White has been promoted to Vice President, Controller and Chief Accounting Officer, effective March 1, 2022. White will replace Gary Wilson, who is retiring following more than 7 years with the company as previously announced September 23, 2021.
CCRN

Hot Stocks

14:07 EST Cross Country Healthcare promotes Colin McDonald to Chief HR Officer - Cross Country Healthcare announces that Colin McDonald has been promoted from Senior Vice President of Human Resources to Chief Human Resources Officer. "McDonald serves as Cross Country Healthcare's diversity and inclusion officer in addition to being part of the executive leadership team... Prior to joining Cross Country Healthcare, Colin held leadership positions at Carnival Cruise Lines, RandCol Staffing and Citrix," the company stated.
HCC

Hot Stocks

14:05 EST Warrior Met Coal raises cash dividend by 20% to 6c per share - Warrior Met Coal announced that its board of directors has approved an increase in the regular quarterly cash dividend by 20%. The board of directors declared on February 18 a regular quarterly cash dividend of 6c per share to be paid on March 10 to stockholders of record as of the close of business on March 3.
TSE

Hot Stocks

14:04 EST Trinseo appoints Andre Lanning as Chief Commercial Officer - Trinseo announced that it has created two new Executive Leadership Team positions - the roles of Chief Technology Officer, or CTO, and Chief Commercial Officer, or CCO. Effective March 1, Andre Lanning will assume the newly created role of Senior Vice President and Chief Commercial Officer. As CCO, Lanning will be "responsible for stepping up commercial excellence, delivering commercial synergies and realizing the organic growth opportunities identified as part of the company's transformation strategy," the company said. Lanning will remain as a member of Trinseo's Executive Management team and will continue to lead Trinseo's Strategy, Corporate Development and Marketing Communications function until a successor has been appointed. Trinseo has launched the search for Lanning's successor as well as the CTO position, it noted.
LNVGY

Hot Stocks

14:01 EST Lenovo selected as constituent stock of Hang Seng Index - The Hang Seng Indexes Company Limited has announced that effective March 7, Lenovo Group (LNVGY) will be included as a constituent stock on the Hang Seng Index, "Hong Kong's benchmark stock gauge." "This selection means Lenovo is included alongside other 'blue chip' companies listed on the Hong Kong Stock Exchange such as HSBC, Tencent, and Meituan. Lenovo's addition to the Index follows the review of the Hang Seng Family of Indexes for the quarter ending 31st December 2021," the company stated.
BNTX MDGEF

Hot Stocks

13:59 EST BioNTech, Medigene announce global TCR collaboration - BioNTech SE (BNTX) and Medigene AG (MDGEF) announced that they have entered a multi-target research collaboration to develop T cell receptor, or TCR, based immunotherapies against cancer. The initial term of the collaboration is three years. Medigene will contribute its proprietary TCR discovery platform for the development of TCRs against multiple solid tumor targets nominated by BioNTech. Medigene's automated, high throughput TCR discovery platform is designed to bypass central tolerance to yield high affinity TCRs. T cell therapy has become a disruptive medical innovation in the treatment of patients with cancer. Engineered TCR-modified T cells, or TCR-T cells, are reprogrammed to express a TCR that can recognize specific antigens only present on tumor cells, thereby enabling a precise and potent immune response to attack a patient's tumor. BioNTech will acquire Medigene's next generation preclinical TCR program, which combines TCR-4 of Medigene's MDG10XX program targeting PRAME with Medigene's proprietary PD1-41BB switch receptor technology. BioNTech will also obtain the exclusive option to acquire additional existing TCRs in Medigene's discovery pipeline and will receive licenses to the company's PD1-41BB switch receptor and precision pairing library. This has the potential to augment TCR cell therapy efficacy and can be applied to all BioNTech cell therapy programs. Under the terms of the agreement, Medigene will receive EUR 26 million upfront, as well as research funding for the period of the collaboration. BioNTech will be responsible for global development and hold exclusive worldwide commercialization rights on all TCR therapies resulting from this research collaboration. Medigene will be eligible to receive development, regulatory and commercial milestone payments up to a triple digit million EUR amount per program in addition to tiered deferred option payments on global net sales for products based on TCRs arising from the collaboration and royalties on products utilizing at least one of the licensed technologies. "This collaboration with Medigene expands our cell therapy portfolio and TCR discovery capabilities, and further strengthens our ability to be a leader in the rapidly emerging field of engineered cell therapies. We look forward to working closely with Medigene to develop new treatments which address solid tumors with high unmet medical need," said Ugur Sahin, M.D., CEO and Co-Founder of BioNTech.
AZN DSNKY

Hot Stocks

13:57 EST AstraZeneca reports 'positive high-level results' from DESTINY-Breast04 trial - AstraZeneca (AZN) reported "positive high-level results" from the pivotal DESTINY-Breast04 Phase 3 trial showed Enhertu demonstrated a statistically significant and clinically meaningful improvement in both progression-free survival, or PFS, and overall survival, or OS, in patients with HER2-low unresectable and/or metastatic breast cancer regardless of hormone receptor status versus physician's choice of chemotherapy. Enhertu is a HER2-directed antibody drug conjugate being jointly developed by AstraZeneca and Daiichi Sankyo (DSNKY). DESTINY-Breast04 met its primary endpoint, where Enhertu demonstrated superior PFS in previously treated patients with HR-positive HER2-low metastatic breast cancer compared to the standard-of-care chemotherapy. The trial met the key secondary endpoint of PFS in patients with HER2-low metastatic breast cancer regardless of HR status. The trial also met the key secondary endpoints of OS in patients with HR-positive disease and in patients regardless of HR status at interim analysis. The safety profile of Enhertu was consistent with previous clinical trials, with no new safety concerns identified. Overall interstitial lung disease rates were consistent with that observed in late-line HER2-positive breast cancer trials of Enhertu, with a lower rate of Grade 5 ILD observed as determined by an independent adjudication committee, the company said. The data will be presented at a forthcoming medical meeting and shared with global health authorities. Susan Galbraith, Executive Vice President, Oncology R&D, AstraZeneca said: "Today's historic news from DESTINY-Breast04 could reshape how breast cancer is classified and treated. A HER2-directed therapy has never-before shown a benefit in patients with HER2-low metastatic breast cancer. These results for Enhertu are a huge step forward and could potentially expand our ability to target the full spectrum of HER2 expression, validating the need to change the way we categorize and treat breast cancer."
CLF

Hot Stocks

13:10 EST Cleveland-Cliffs notifies of flat-rolled price increase - Cleveland-Cliffs announced it will notify its customers that, based on a stronger inflow of new orders, it is increasing current spot market base prices for all April orders of carbon hot rolled, cold rolled and coated steel products by a minimum of $50 per net ton. Lourenco Goncalves, Cliffs' Chairman, President and CEO, said, "Our strategy of increasing productivity at our ironmaking and steelmaking facilities through the use of both in-house produced HBI and additional scrap has allowed us to reduce coke rate and consequently reduce CO2 emissions, as well as to stretch hot metal utilization and still be able to produce similar amounts of crude steel with fewer blast furnaces. Said another way, by concentrating the operation and maximizing productivity at IH#7 we are improving our carbon footprint and, at the same time, lowering our cost structure for the same level of steel production and shipments. Most importantly, as we have enough job openings on site for all impacted employees, we are now able to fill several available job openings at Indiana Harbor Works with the current workforce of IH#4."
CLF

Hot Stocks

13:09 EST Cleveland-Cliffs announces indefinite idle of Indiana Harbor #4 blast furnace - Cleveland-Cliffs announced that it will indefinitely idle its Indiana Harbor #4 blast furnace. "This action is a result of the successful implementation of operational improvements, particularly the addition of significant amounts of HBI to the burden of blast furnaces and the maximization of scrap usage in BOFs. The employees allocated to IH#4 will be reassigned to other positions within Indiana Harbor Works, as the number of available job openings at the Indiana Harbor complex exceeds the amount of jobs associated with IH#4. The company will continue normal operations of the entire Indiana Harbor Works, including its two steel shops, the hot strip mill and all its finishing facilities, as well as the nearby Riverdale Works. With both Indiana Harbor blast furnaces #3 and #4 now indefinitely idled, going forward, all downstream operations including Riverdale Works will be supplied exclusively by the company's flagship high-productivity IH#7 blast furnace. The IH#4 furnace, which has a production capacity of 2.1 million net tons of hot metal per year, is expected to cease production within the next two months. This action will reduce the number of operational blast furnaces in Cliffs' footprint from 8 to 7. The company does not expect any change to full-year 2022 steel shipment volumes as a result of the indefinite idle of IH#4," the company said.
APA TTE

Hot Stocks

13:07 EST APA Corp. announces oil discovery at Krabdagu-1 well offshore Suriname - APA Corporation (APA) announced an oil discovery at the Krabdagu-1, or KBD-1, exploration well. KBD-1 is located on Block 58 offshore Suriname, approximately 18 kilometers southeast of the Sapakara South-1 appraisal well. APA Suriname holds a 50% working interest in the block, with TotalEnergies (TTE), the operator, holding a 50% working interest. While the rig is on location, TotalEnergies will progress with drill stem and other wellbore testing to assess the resource potential and productivity of two primary reservoirs. "We are very pleased with the Krabdagu exploration well, which confirms our geologic and geophysical models and de-risks additional prospects we have matured in the area," said Tracey Henderson, SVP, Exploration. "The promising discovery at Krabdagu is another important step toward achieving our first FID in Block 58 offshore Suriname, and we look forward to continuing our exploration and appraisal programs," added John Christmann IV, APA's CEO and president.
ABT

Hot Stocks

09:01 EST Abbott announces FDA approval for CardioMEMS HF System expansion - Abbott announced that the Food and Drug Administration has approved an expanded indication for the company's CardioMEMS HF System to support the care of more people living with heart failure. With the expanded indication, an additional 1.2M U.S. patients are now eligible for advanced monitoring with the CardioMEMS sensor, which marks a significant increase over the current addressable population, the company said in a statement. The sensor provides an early warning system enabling doctors to protect against worsening heart failure.
PRIM

Hot Stocks

08:57 EST Primoris announces two projects with combined value of over $75M - Primoris Services announced two projects with a combined value of more than $75M. The awards were secured by the company's Energy/Renewables Segment and are located in the Gulf Coast region. The projects will commence in Q1 of 2022 and are expected to be complete in Q1 of 2023. The projects are for industrial and civil work. The first project is for the construction of a dam located in Florida. The second project is for the mechanical scope of a hydrogen producing Steam Methane Reformer.
RNG ZM

Hot Stocks

08:55 EST RingCentral, Zoom Video agree with withdraw various legal proceedings - RingCentral (RNG) and Zoom Video Communications (ZM) announced that the companies have agreed to mutually withdraw from various legal proceedings and will continue to work together while RingCentral transitions existing customers from the legacy RingCentral Meetings service to the new RingCentral Video. The agreement resolves all of the parties' claims in the litigation, and the parties have dismissed their complaints with prejudice. "We are pleased to have resolved this matter in a way that allows the parties to continue the wind down of their partnership," said Jeff True, General Counsel at Zoom. "Today's agreement with Zoom removes any uncertainty in the ability of RingCentral's existing customers to migrate to RingCentral Video in an orderly manner, and in a time frame that is customer driven," said John Marlow, Chief Administrative Officer and General Counsel at RingCentral. Additional details regarding the settlement agreement were not disclosed.
ERJ

Hot Stocks

08:53 EST Embraer announces 55 jet deliveries in Q4 - Embraer said it delivered 55 jets in Q4 of 2021, of which 16 were commercial aircraft and 39 were executive jets. The company delivered a total of 141 jets in 2021, comprised of 48 commercial aircraft and 93 executive jets. As of December 31, the firm order backlog totaled $17B, reaching its highest value since the second quarter of 2018. The current backlog value already reflects the outcome of the negotiations with the Brazilian Air Force for the reduction from 28 to 22 the total number of KC-390 Millennium aircraft to be delivered under the terms of the amendments to the agreements.
LAIX

Hot Stocks

08:52 EST Laix announces one-for-14 reverse ADS split via change ratio - Laix announced that it plans to change the ratio of its American depositary shares to its class A ordinary shares from the current ADS ratio of one ADS to one class A ordinary share to a new ADS ratio of one ADS to 14 class A ordinary shares. The company anticipates that the change in the ADS ratio will be effective on or about March 4. For Laix's ADS holders, the change in the ADS ratio will have the same effect as a one-for-fourteen reverse ADS split.
USAP

Hot Stocks

08:49 EST Universal Stainless & Alloy raises base price of bar products by 3%-10% - Universal Stainless & Alloy Products announced a base price increase of 3% to 10% on bar products. The increase goes into effect immediately for all new orders. Current material and energy surcharges will remain in effect. Chris Zimmer, Executive Vice President and Chief Commercial Officer, commented, "We are in an environment that has brought sharp inflationary cost increases to nearly all areas of our business, and it is necessary for us to adjust our pricing to keep up with this higher cost burden. We will continue to take the actions necessary to manage our organization and maintain our class leading customer service levels and exceptional production quality standard."
WLK

Hot Stocks

08:47 EST Westlake announces plans to reduce carbon dioxide emissions - Westlake announced its target to reduce Scope 1 and Scope 2 CO2 equivalent emissions per ton of production by 20% by 2030 from a 2016 baseline. "To further reduce its carbon footprint, Westlake's strategy is to optimally allocate capital to both proven and emerging technologies, including additional product and operational innovations. This strategy includes energy-efficiency projects, increasing power from less carbon-intensive electricity providers, adding more hydrogen as a fuel gas, and other continuous operational improvements," the company said in a statement. In 2022, Westlake plans to continue reporting sustainability metrics informed by the Sustainability Accounting Standards Board voluntary disclosure framework, the Task Force on Climate-Related Financial Disclosures guidance, and the Global Reporting Initiative framework.
AZN

Hot Stocks

08:12 EST AstraZeneca says Enhertu improved breast cancer survival in Phase III study - AstraZeneca says results from the pivotal DESTINY-Breast04 Phase III trial showed Enhertu demonstrated a "statistically significant and clinically meaningful" improvement in both progression-free survival and overall survival in patients with HER2-low unresectable and/or metastatic breast cancer regardless of hormone receptor status versus physician's choice of chemotherapy. Enhertu is a HER2-directed antibody drug conjugate being jointly developed by AstraZeneca and Daiichi Sankyo. Up to 55% of all patients with breast cancer have tumors with a HER2 IHC score of 1+, or 2+ in combination with a negative immunohistochemistry test, a level of HER2 expression not currently eligible for HER2-targeted therapy. HER2-low expression occurs in both HR-positive and HR-negative disease, AstraZeneca said in a statement. DESTINY-Breast04 met its primary endpoint, where Enhertu demonstrated superior PFS in previously treated patients with HR-positive HER2-low metastatic breast cancer compared to the standard-of-care chemotherapy, the company added. Reference Link